Immediate Effects of Kinesio Tape on Median Nerve's Mechanosensitivity

Healthy Clinical Trial

Official title:

Immediate Effects of Kinesio Tape on Median Nerve's Mechanosensitivity, Measured by the Upper Limb Neurodynamic Test 1 (ULNT1) in Healthy Participants: A Randomized Controlled Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05250076
• Other study ID #: FISIO-2-28102019
• Status: Completed
• Phase: N/A
• Start date: February 11, 2022
• Est. completion date: March 26, 2022

Study information

• Verified date: May 2022
• Source: University Fernando Pessoa
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to verify the immediate effects of Kinesio Tape on median nerve's mechanosensitivity, measured by the upper limb neurodynamic test 1 (ULNT1) in healthy participants.

Description:

After completing the socio-demographic and clinical questionnaire, the participants will be randomly assigned into two designated groups, the Intervention Group (IG; n = 30) (Kinesio tape throughout the median nerve course) and the Control Group (CG; n = 30) (remained at rest for 5 minutes), using the software www.graphpad.com/quickcals.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 60
• Est. completion date: March 26, 2022
• Est. primary completion date: February 26, 2022
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 35 Years

Eligibility

Inclusion Criteria:

• Healthy university students of both genders with normal mobility of the joints of the upper quadrant of the body

Exclusion Criteria:

• Deformities in the upper quadrant region of the body;

• Complaints in this region in the last 6 months;

• Surgical procedures or musculoskeletal, cardiac, renal, metabolic, neurological and or oncological pathologies of the upper quadrant that may disturb nerve function;

• Not present any mechanosensitive response to ULNT1;

• Pregnant women;

• Ingestion of non-steroidal anti-inflammatory drugs or consumption of any type of narcotic drugs and participants who have drunk alcohol in the last 12 hours.

Related Conditions & MeSH terms

• Healthy

Intervention

Device:
• Kinesio Tape
The beige Kinesio Tape (Prim Tape®) will be applied, from distal to proximal, 5cm wide, cut in "I" and with tension below 50%. The Kinesio Tape will be placed along the entire path of the median nerve, from the wrist to the armpit. The participants will remain in the supine position on a treatment table (Posturarte® Olympic), without inclination.

Locations

Country	Name	City	State
Portugal	Ricardo Cardoso	Porto

Sponsors (1)

Lead Sponsor	Collaborator
University Fernando Pessoa

Country where clinical trial is conducted

Portugal, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	change in elbow extension range of motion measured by smartphone	Data will be collected in two moments: baseline (Moment 0) and after the application of Kinesio Tape for intervention group or after a resting period for control group (Moment 1).; Moment 0 will consist in performing the ULNT1 on the dominant upper limb for each participant. The participants will remain in a supine position on a treatment table with the body aligned, exposing the test forearm for the placement of the smartphone through an armband. The head and cervical spine will be stabilized at the maximum comfortable lateral inclination using a foam pillow. The ULNT1 sequence used was: (1) maximum contralateral cervical inclination; (2) arm at 90º of shoulder abduction preventing scapular elevation; (3) 90º of external rotation of the shoulder and elbow flexion at 90º (defined as the initial position or 0º of range of motion under test); (4) supination of the forearm; (5) wrist and fingers extension; and (6) elbow extension.	[Time Frame: Baseline (Moment 0), Immediately after intervention or control (Moment 1) .]]